{"id":3404,"date":"2026-02-08T14:42:11","date_gmt":"2026-02-08T14:42:11","guid":{"rendered":"https:\/\/www.finznest.com\/blog\/1-stock-to-buy-1-stock-to-sell-this-week-cisco-moderna\/"},"modified":"2026-02-08T14:42:11","modified_gmt":"2026-02-08T14:42:11","slug":"1-stock-to-buy-1-stock-to-sell-this-week-cisco-moderna","status":"publish","type":"post","link":"https:\/\/www.finznest.com\/blog\/1-stock-to-buy-1-stock-to-sell-this-week-cisco-moderna\/","title":{"rendered":"1 Stock to Buy, 1 Stock to Sell This Week: Cisco, Moderna"},"content":{"rendered":"<div>\n<ul type=\"disc\">\n<li>U.S. jobs report, CPI inflation data, retail sales, and more earnings will be in focus this week.<\/li>\n<li>Cisco is projected to deliver strong earnings and solid guidance, making it a high-probability winner this week.<\/li>\n<li>Moderna\u2019s shrinking revenue, expected losses position it for potential downside this week.<\/li>\n<li>\n<\/li>\n<\/ul>\n<p>Stocks on Wall Street rallied on Friday to record their strongest gain in months, as the  closed above the historic 50,000 mark for the first time ever.<\/p>\n<p>Friday\u2019s advance followed three straight days of losses marked by worries about artificial intelligence, with several software companies hit especially hard amid concerns that AI could create more competition.<\/p>\n<p><\/p>\n<p><em>Source: Investing.com<\/em><\/p>\n<p>For the week, the benchmark  and tech-heavy Nasdaq Composite lost 0.1% and 1.8% respectively, while the 30-stock Dow rose 2.5%, and the small cap  jumped 1.8%.<\/p>\n<p>More volatility could be in store in the coming days as investors assess the outlook for the economy, inflation, interest rates and corporate earnings.<\/p>\n<p>On the economic calendar, delayed retail sales data for December drops on Tuesday. But Wednesday\u2019s delayed release of the U.S. January jobs report could be more pivotal amid fears about the labor market. In addition, January CPI data due Friday will give more indications into whether inflation is truly under control.<img decoding=\"async\" title=\"Weekly Economic Events\" src=\"https:\/\/d1-invdn-com.investing.com\/content\/337025ef2d0e721536c2ec2dd52a7923.png\" alt=\"Weekly Economic Events\" width=\"\" height=\"\"\/><\/p>\n<p><em>Source: Investing.com<\/em><\/p>\n<p>Earnings season also continues apace, with several noteworthy reports set to drop, including Coca-Cola, McDonald\u2019s, Ford, , Robinhood, Coinbase, Arista Networks, as well as software stocks such as AppLovin, Shopify, and Datadog.<\/p>\n<p>Regardless of which direction the market goes, below I highlight one stock likely to be in demand and another which could see fresh downside.\u00a0Remember though, my timeframe is <em>just<\/em><em>\u00a0<\/em>for the week ahead, Monday, February 9 &#8211; Friday, Feb. 13.<\/p>\n<h2><strong>Stock To Buy: Cisco<\/strong><strong>\u00a0<\/strong><\/h2>\n<p>Cisco\u2019s latest earnings report is the key catalyst for the stock this week, and the risk\u2011reward skew looks favorable. CSCO is scheduled to deliver its fiscal second quarter update after the closing bell on Wednesday at 4:05PM ET.<\/p>\n<p>Expectations aren\u2019t overly stretched, which means a modest revenue and EPS beat, plus stable or slightly upbeat guidance, could be enough to drive a post\u2011earnings move higher.<\/p>\n<p>Analyst sentiment has been notably positive heading into the print. According to InvestingPro data, 14 of the last 16 EPS revisions have been to the upside, highlighting confidence in Cisco\u2019s continued expansion.<img decoding=\"async\" title=\"Cisco Earnings Page\" src=\"https:\/\/d1-invdn-com.investing.com\/content\/d05c6ccbca87954905ad902b0cbad758.png\" alt=\"Cisco Earnings Page\" width=\"\" height=\"\"\/><\/p>\n<p><em>Source: InvestingPro<\/em><\/p>\n<p>As a dominant player in networking hardware, security, and increasingly AI infrastructure, <span itemscope=\"\" itemtype=\"http:\/\/schema.org\/Corporation\"><span itemprop=\"name\">Cisco<\/span><\/span> benefits from several trends that can underpin a solid quarter even in a mixed macro backdrop.<\/p>\n<p>Consensus estimates call for Cisco to post adjusted earnings per share of $1.02, up 9% from the year-ago period. Revenue is forecast to increase 8% annually to $15.1 billion, driven by AI demand and robust product sales.<\/p>\n<p>Analysts expect long-term upside from an enterprise market partnership for AI networking products with Nvidia. Cisco\u2019s security business under-performed in fiscal Q1 despite the acquisition of Splunk and analysts will look for a rebound.<img decoding=\"async\" title=\"Cisco Daily Chart\" src=\"https:\/\/d1-invdn-com.investing.com\/content\/fdf8b8663bdca9a58a6f11e57c8f50a0.png\" alt=\"Cisco Daily Chart\" width=\"\" height=\"\"\/><\/p>\n<p><em>Source: Investing.com<\/em><\/p>\n<p>Cisco\u2019s stock has been on a tear, hitting a series of fresh 52-week highs in recent sessions. Shares closed at $84.82 on Friday, signaling powerful momentum heading into earnings.<\/p>\n<p>Furthermore, valuation and sentiment work in Cisco\u2019s favor as well. The stock typically trades at a reasonable earnings multiple relative to both broader tech and its own history, and it offers an attractive dividend yield backed by strong free cash flow.<\/p>\n<p><strong>Trade Setup:<\/strong><\/p>\n<ul type=\"disc\">\n<li><strong>Entry:<\/strong>\u00a0Around current levels (~$84-85)<\/li>\n<li><strong>Exit Target:<\/strong>\u00a0$90-$95 (gain ~5.8%-10.8%)<\/li>\n<li><strong>Stop-Loss:<\/strong>\u00a0$80 (risk ~5.8%)<\/li>\n<\/ul>\n<h2><strong>Stock To Sell: Moderna<\/strong><\/h2>\n<p>, by contrast, faces a more challenging week as it prepares to release its Q4 earnings report ahead of Friday\u2019s opening bell at 6:35AM ET. With implied volatility pointing to a +\/-16% stock move post-earnings, the risk of a miss looms large.<\/p>\n<p>After its spectacular success during the pandemic with its mRNA COVID\u201119 vaccine, the biotech firm has been navigating a difficult transition from one\u2011product dominance to a broader, but still largely unproven, pipeline.<\/p>\n<p>Analysts have grown increasingly bearish on MRNA ahead of the print, slashing their sales estimates by about 14%.<img decoding=\"async\" title=\"Moderna Earnings Page\" src=\"https:\/\/d1-invdn-com.investing.com\/content\/309ac1d556329c3e4afe97fa8e11c1ed.png\" alt=\"Moderna Earnings Page\" width=\"\" height=\"\"\/><\/p>\n<p><em>Source: InvestingPro<\/em><\/p>\n<p>Consensus anticipates a significant loss: EPS around -$2.62 on revenue of $662.8 million, down sharply ~30%+ YoY from sales of $966 million.<\/p>\n<p>The biotech company is now facing revenue growth challenges with limited near-term catalysts to offset weakening demand as vaccine sales continue to decline.<\/p>\n<p>At the same time, R&amp;D and manufacturing spending must remain high to support a deep pipeline in respiratory viruses, oncology, and other indications, which puts pressure on near\u2011term profitability and cash burn.<img decoding=\"async\" title=\"Moderna Daily Chart\" src=\"https:\/\/d1-invdn-com.investing.com\/content\/1012822678f4fe807fe9e78992b96793.png\" alt=\"Moderna Daily Chart\" width=\"\" height=\"\"\/><\/p>\n<p><em>Source: Investing.com<\/em><\/p>\n<p>Moderna\u2019s price has lost steam after a strong recent run, closing at $41.01 on Friday. It\u2019s still up 67.1% over three months and 21.1% in the past month, but last week\u2019s -7% drop suggests fading momentum.<\/p>\n<p>In a market rotating toward growth and AI, high\u2011beta biotech names like this face rotation risks, especially if results miss or guidance disappoints.<\/p>\n<p><strong>Trade Setup:<\/strong><\/p>\n<ul type=\"disc\">\n<li><strong>Entry:<\/strong>\u00a0Around current levels (~$40-41)<\/li>\n<li><strong>Exit Target:<\/strong>\u00a0$35 (gain ~15%)<\/li>\n<li><strong>Stop-Loss:<\/strong>\u00a0$45 (risk ~12.5%)<\/li>\n<\/ul>\n<p>Whether you\u2019re a novice investor or a seasoned trader, leveraging InvestingPro can unlock a world of investment opportunities while minimizing risks amid the challenging market backdrop.<\/p>\n<div style=\"border: 2px solid #ff7f00; background-color: #fff4e6; padding: 15px; border-radius: 8px; font-family: Arial, sans-serif; color: #1a1a1a;\">\n<p><strong>Below are the key ways an InvestingPro subscription can enhance your stock market investing performance:<\/strong><\/p>\n<ul type=\"disc\">\n<li><strong>ProPicks AI:<\/strong> AI-selected stock winners with proven track record.<\/li>\n<li><strong>InvestingPro Fair Value: <\/strong>Instantly find out if a stock is underpriced or overvalued.<\/li>\n<li><strong>Advanced Stock Screener:<\/strong> Search for the best stocks based on hundreds of selected filters, and criteria.<\/li>\n<li><strong>Top Ideas:<\/strong> See what stocks billionaire investors such as Warren Buffett, Michael Burry, and George Soros are buying.<\/li>\n<\/ul>\n<p>Subscribe Here!<\/div>\n<p><strong><em>Disclosure: <\/em><\/strong><strong><em>This is not financial advice. Always conduct your own research.<\/em><\/strong><strong><em>\u00a0<\/em><\/strong><\/p>\n<p><em>At the time of writing, I am long on the S&amp;P 500, and the Nasdaq 100 via the\u00a0, and the Invesco QQQ Trust ETF. I am also long on the Technology Select Sector SPDR ETF. I regularly rebalance my portfolio of individual stocks and ETFs based on ongoing risk assessment of both the macroeconomic environment and companies\u2019 financials.<\/em><em>\u00a0<\/em><\/p>\n<p><em>The views discussed in this article are solely the opinion of the author and should not be taken as investment advice.<\/em><\/p>\n<p><em>Follow Jesse Cohen on X\/Twitter <\/em><a href=\"https:\/\/twitter.com\/JesseCohenInv\" target=\"_blank\" rel=\"noopener\"><em>@JesseCohenInv<\/em><\/a><em> for more stock market analysis and insight.<\/em><\/p>\n<\/div>\n<p><script async src=\"\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><script id=\"fb_pixel\" data-nscript=\"beforeInteractive\">!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https:\/\/connect.facebook.net\/en_US\/fbevents.js');<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>U.S. jobs report, CPI inflation data, retail sales, and more earnings will be in focus this week. Cisco is projected to deliver strong earnings and solid guidance, making it a high-probability winner this week. Moderna\u2019s shrinking revenue, expected losses position it for potential downside this week. Stocks on Wall Street rallied on Friday to record [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3405,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[228,601,1263,292,229,293],"class_list":["post-3404","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-buy","tag-cisco","tag-moderna","tag-sell","tag-stock","tag-week"],"_links":{"self":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/3404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/comments?post=3404"}],"version-history":[{"count":0,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/3404\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media\/3405"}],"wp:attachment":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media?parent=3404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/categories?post=3404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/tags?post=3404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}